MDXG FY 2014 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$677M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$118M+99.8% YoY

Gross Profit

$106M89.3% margin

Operating Income

$7M6.0% margin

Net Income

$6M5.3% margin

EPS (Diluted)

$0.05

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$14M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$109M

Total Liabilities

$20M

Stockholders' Equity

$89M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$118M	$59M	+99.8%
Gross Profit	$106M	$50M	+111.7%
Operating Income	$7M	-$3M	+369.0%
Net Income	$6M	-$4M	+251.3%